Cao, Y., Liu, H., Zhang, H., Lin, C., Li, R., Wu, S., . . . Xu, J. (2016). CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients. Oncotarget.
استشهاد بنمط شيكاغوCao, Yifan, et al. "CXC Chemokine Receptor 1 Predicts Postoperative Prognosis and Chemotherapeutic Benefits for TNM II and III Resectable Gastric Cancer Patients." Oncotarget 2016.
MLA استشهادCao, Yifan, et al. "CXC Chemokine Receptor 1 Predicts Postoperative Prognosis and Chemotherapeutic Benefits for TNM II and III Resectable Gastric Cancer Patients." Oncotarget 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.